Sorrento Therapeutics Inc (SRNE): But analysts' price target was $24.0...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	120
Posts	9122
Boards Moderated	0
Alias Born	07/17/2005

Alyssa

Re: raydawg post# 2149

Friday, 05/15/2020 3:09:05 PM

Friday, May 15, 2020 3:09:05 PM

But analysts' price target was $24.00 for a long time BEFORE today's awesome news. The stock has been beaten to a pulp for no good reason. I wonder what they would say today about this little gem. Fingers crossed for successful human trials! This could be a HUGE part of the solution.

From ETrade:

Avg. Price Target
$24.00

250.88% Upside

High $24.00
250.88% Upside

Low $24.00
250.88% Upside

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM